The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1 alpha and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen

Stephen B Fox; Daniele Generali; Alfredo Berruti; Maria P Brizzi; Leticia Campo; Simone Bonardi; Alessandra Bersiga; Giovanni Allevi; Manuela Milani; Sergio Aguggini; Teresa Mele; Luigi Dogliotti; Alberto Bottini; Adrian L Harris

Journal article

The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1 alpha and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen

Stephen B Fox, Daniele Generali, Alfredo Berruti, Maria P Brizzi, Leticia Campo, Simone Bonardi, Alessandra Bersiga, Giovanni Allevi, Manuela Milani, Sergio Aguggini, Teresa Mele, Luigi Dogliotti, Alberto Bottini, Adrian L Harris

Breast Cancer Research | BMC | Published : 2011

DOI: 10.1186/bcr2825

University of Melbourne Researchers

Stephen Fox Author The Sir Peter MacCallum Department of Oncology

Grants

Awarded by Progetto Ricerca Finalizzata type 3

Awarded by Cancer Research UK

Funding Acknowledgements

The present study was supported by the Victorian Breast Cancer Research Consortium, Australia, the Association Amici dell'Ospedale di Cremona, APOM Onlus, the Regione Piemonte, Progetto Ricerca Finalizzata type 3 no 24723, Cancer Research UK and the Oxford NIHR Biomedical Research Programme.